A dual acting drug for enhancing radiotherapeutic benefit
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA180316
- Recipient
-
BCN Biosciences LLC UEI NXFXKJGKWNM8
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $209,208
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- Pasadena, CA 91107, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $25,000 | |
| Original award | $184,208 |
Quick answers
Who received award R43CA180316?
R43CA180316 was awarded to BCN Biosciences LLC by National Institutes of Health (Department of Health and Human Services) on May 19, 2014.
How much is award R43CA180316 worth?
$209,208 has been obligated on R43CA180316.
Which agency awarded R43CA180316?
National Institutes of Health (Department of Health and Human Services) awarded R43CA180316, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award